Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 12Breast Neoplasms 11Lung Neoplasms 6Prostatic Neoplasms 5Colorectal Neoplasms 5Uterine Cervical Neoplasms 4Thyroid Neoplasms 2Smoking Cessation 2Motor Activity 2Lymphoma 2Hematologic Neoplasms 2Communication 2Uveal Melanoma 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tobacco Use Disorder 1Tobacco Use Cessation 1Thyroid Diseases 1Substance-Related Disorders 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Sexual Dysfunction, Physiological 1Sedentary Behavior 1Rectal Neoplasms 1Patient Preference 1Patient Acceptance of Health Care 1Papillomavirus Infections 1Papillary Thyroid Microcarcinoma 1Neoplasms, Plasma Cell 1

Interventions

Paclitaxel 95Carboplatin 76pembrolizumab 72Cisplatin 28Bevacizumab 27Surveys and Questionnaires 23Radiotherapy 22Letrozole 22Doxorubicin 21Megestrol Acetate 20olaparib 19lenvatinib 19Taxes 17Specimen Handling 17Docetaxel 17Nivolumab 16Magnetic Resonance Spectroscopy 16dostarlimab 15Metformin 15Observation 13Gemcitabine 13Blood Specimen Collection 13Biopsy 13durvalumab 12Medroxyprogesterone Acetate 12Trastuzumab 11Indocyanine Green 11Fulvestrant 11temsirolimus 10abemaciclib 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Focus Groups × Clear all
NCT04474184 2023-11-18

Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates

Mayo Clinic

Phase 1 Completed
33 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡